Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil

Detalhes bibliográficos
Autor(a) principal: Arrepia, Diva Barrio
Data de Publicação: 2015
Outros Autores: Costa, Jorge Carlos, Tabak, David
Tipo de documento: Artigo
Idioma: por
Título da fonte: Vigilância Sanitária em Debate
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439
Resumo: The aim of the study was to investigate the potential contribution that the obligatory registration of active pharmaceutical ingredients (APIs) had on the establishment of regulatory isonomy between API producers in Brazil and international producers. In addition, this study aimed to evaluate the effect of this isonomy on the re-establishment of local production. The investigation identified the registration of 20 APIs, defined as priorities by the Brazilian National Agency for the Sanitary Surveillance (ANVISA), in the period 2010–2012. The methodology used included the collection of data from national and international, public and private, databases that allowed the construction of tables and graphs. The results demonstrated that registration of APIs is an important instrument for public politics leading to regulatory isonomy. However, the period under analysis was not sufficiently long to confirm that the RDC, combined with other governmental actions, may have promoted the increase in production, although some signs exist that this will eventually happen.
id FIOCRUZ-9_7b27918cad9799f0110337e3bfe84de4
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/439
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
repository_id_str
spelling Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in BrazilRegistro de insumos farmacêuticos ativos: impactos e reflexos sobre as indústrias farmoquímica e farmacêutica instaladas no BrasilInsumoIsonomiaFabricaçãoImportaçãoRegistroActiveIsonomyProductionImportationRegistrationThe aim of the study was to investigate the potential contribution that the obligatory registration of active pharmaceutical ingredients (APIs) had on the establishment of regulatory isonomy between API producers in Brazil and international producers. In addition, this study aimed to evaluate the effect of this isonomy on the re-establishment of local production. The investigation identified the registration of 20 APIs, defined as priorities by the Brazilian National Agency for the Sanitary Surveillance (ANVISA), in the period 2010–2012. The methodology used included the collection of data from national and international, public and private, databases that allowed the construction of tables and graphs. The results demonstrated that registration of APIs is an important instrument for public politics leading to regulatory isonomy. However, the period under analysis was not sufficiently long to confirm that the RDC, combined with other governmental actions, may have promoted the increase in production, although some signs exist that this will eventually happen.O presente estudo teve por objetivo investigar e avaliar a potencial contribuição que a obrigatoriedade do registro de Insumos Farmacêuticos Ativos (IFAs) teve no estabelecimento da isonomia regulatória entre o fabricante de IFA no Brasil e o fabricante internacional e a efetividade que essa isonomia teve no restabelecimento da produção local desses produtos. A pesquisa levou à identificação dos registros dos 20 IFAs, definidos como prioritários pela Agência Nacional de Vigilância Sanitária (ANVISA), no período 2010-2012. A metodologia utilizada compreendeu o levantamento de dados de bases nacionais e internacionais, públicas e privadas, que possibilitaram a construção de tabelas e gráficos, levando às informações da pesquisa. Os resultados demonstraram que o registro do IFA é um importante instrumento de política pública na obtenção da isonomia regulatória. Porém, o tempo de análise não foi suficientemente longo para assegurar que a mesma, associada a outras ações do governo para o incentivo à produção local de IFAs, tenha sido capaz de promover o aumento da fabricação desses produtos, apesar de haver sinalizações de que isso acontecerá.Instituto Nacional de Controle de Qualidade em Saúde2015-05-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/vnd.openxmlformats-officedocument.wordprocessingml.documenthttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/43910.3395/2317-269x.00439Health Surveillance under Debate: Society, Science & Technology ; Vol. 3 No. 2 (2015): May; 9-19Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 3 Núm. 2 (2015): Puede; 9-19Vigil Sanit Debate, Rio de Janeiro; v. 3 n. 2 (2015): Maio; 9-192317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439/224https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439/676https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439/677Copyright (c) 2015 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessArrepia, Diva BarrioCosta, Jorge CarlosTabak, David2023-06-27T14:59:48Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/439Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T14:59:48Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
Registro de insumos farmacêuticos ativos: impactos e reflexos sobre as indústrias farmoquímica e farmacêutica instaladas no Brasil
title Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
spellingShingle Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
Arrepia, Diva Barrio
Insumo
Isonomia
Fabricação
Importação
Registro
Active
Isonomy
Production
Importation
Registration
title_short Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
title_full Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
title_fullStr Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
title_full_unstemmed Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
title_sort Registration of active pharmaceutical Ingredients: impacts and repercussions on the pharmochemical and pharmaceutical industries in Brazil
author Arrepia, Diva Barrio
author_facet Arrepia, Diva Barrio
Costa, Jorge Carlos
Tabak, David
author_role author
author2 Costa, Jorge Carlos
Tabak, David
author2_role author
author
dc.contributor.author.fl_str_mv Arrepia, Diva Barrio
Costa, Jorge Carlos
Tabak, David
dc.subject.por.fl_str_mv Insumo
Isonomia
Fabricação
Importação
Registro
Active
Isonomy
Production
Importation
Registration
topic Insumo
Isonomia
Fabricação
Importação
Registro
Active
Isonomy
Production
Importation
Registration
description The aim of the study was to investigate the potential contribution that the obligatory registration of active pharmaceutical ingredients (APIs) had on the establishment of regulatory isonomy between API producers in Brazil and international producers. In addition, this study aimed to evaluate the effect of this isonomy on the re-establishment of local production. The investigation identified the registration of 20 APIs, defined as priorities by the Brazilian National Agency for the Sanitary Surveillance (ANVISA), in the period 2010–2012. The methodology used included the collection of data from national and international, public and private, databases that allowed the construction of tables and graphs. The results demonstrated that registration of APIs is an important instrument for public politics leading to regulatory isonomy. However, the period under analysis was not sufficiently long to confirm that the RDC, combined with other governmental actions, may have promoted the increase in production, although some signs exist that this will eventually happen.
publishDate 2015
dc.date.none.fl_str_mv 2015-05-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439
10.3395/2317-269x.00439
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439
identifier_str_mv 10.3395/2317-269x.00439
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439/224
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439/676
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/439/677
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/vnd.openxmlformats-officedocument.wordprocessingml.document
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; Vol. 3 No. 2 (2015): May; 9-19
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 3 Núm. 2 (2015): Puede; 9-19
Vigil Sanit Debate, Rio de Janeiro; v. 3 n. 2 (2015): Maio; 9-19
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1797042044113256448